Clinical Trial Update: Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of HTU-520 for distal subungual onychomycosis of the toenail has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• HTU-520

Snippet

Sponsor: Hisamitsu Pharmaceutical Co., Inc. | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED